Several of the proteins in the pathways pertinent to the common T2D-AD pathology, such as APOA1, PSEN2, PNLIP, LPL, and IGHG1 are either Orlistat’s targets themselves or are in the close vicinity of the targets. This evidence concerns the gene LPL and Alzheimer disease.